Related references
Note: Only part of the references are listed.Progress in filovirus vaccine development: evaluating the potential for clinical use
Darryl Falzarano et al.
EXPERT REVIEW OF VACCINES (2011)
Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana
Waranyoo Phoolcharoen et al.
PLANT BIOTECHNOLOGY JOURNAL (2011)
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
Larry Zeitlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector
William D. Pratt et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase
Brian C. Geyer et al.
PLANT BIOTECHNOLOGY JOURNAL (2010)
Prospects for immunisation against Marburg and Ebola viruses
Thomas W. Geisbert et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity
Jun Du et al.
VACCINE (2010)
Intrinsic Cellular Defenses against Virus Infection by Antiviral Type I Interferon
Kyung-Hyun Boo et al.
YONSEI MEDICAL JOURNAL (2010)
A DNA Replicon System for Rapid High-Level Production of Virus-Like Particles in Plants
Zhong Huang et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2009)
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections
Dana L. Swenson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant:: therapeutic activity against human cervical cancer in a rodent model
Zhengrong Cui et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo
Judith M. H. de Jong et al.
MOLECULAR IMMUNOLOGY (2006)
The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: Relation to central nervous system antitumor immunity
RM Prins et al.
JOURNAL OF IMMUNOLOGY (2006)
Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants
D Chargelegue et al.
INFECTION AND IMMUNITY (2005)
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection
KL Warfield et al.
JOURNAL OF IMMUNOLOGY (2005)
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection
T Ichinohe et al.
JOURNAL OF VIROLOGY (2005)
Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA
AA Ashkar et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Epitopes involved in antibody-mediated protection from Ebola virus
JA Wilson et al.
SCIENCE (2000)
Share Paper
